BioAmber Inc. announced unaudited consolidated earnings results for the second quarter ended June 30, 2016. For the quarter, the company's revenue was $2,521,000 against $342,000 a year ago. The increase in revenue was entirely attributed to volume growth, with no material change in the average selling price. Operating loss was $7,315,000 against $10,894,000 a year ago. Net income was $2,933,000 against net loss of $14,779,000 a year ago. Net loss attributable to the company’s shareholders was $4,811,000 or $0.17 per basic share against $14,026,000 or $0.0.58 per basic share a year ago. Net cash used in operating activities was $25,675,000 against $15,571,000 a year ago. Acquisition of property and equipment was $364,000 against $52,433, 000 a year ago. Adjusted net loss attributable to the company’s shareholders was $7,132,000 or $0.25 per basic share against $9,529,000 or $0.39 per basic share a year ago.